Taeju Park

6PUBLICATIONS
6CO-AUTHORS
Proteins and peptidesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
Development of Antagonist Peptides of the Crk/CrkL SH2 Domains by Modifying the Peripheral Amino Acid Residues of the YXXP Motif.

|Sep 13, 2025
Choice of Animal Models to Investigate Cell Migration and Invasion in Glioblastoma.

Piyanka Hettiarachchi, Taeju Park

|May 14, 2025
The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkL.

Pegah Farhadi, Taeju Park

|Apr 03, 2021
Crk and CrkL as Therapeutic Targets for Cancer Treatment.

Taeju Park

|Apr 06, 2018
Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Tsukasa Nabekura, Zhiying Chen, Casey Schroeder

|Nov 04, 2016
Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).

Taeju Park, Mateusz Koptyra, Tom Curran

Pageof 1

Frequent Collaborators

1 joint publications

Mateusz Koptyra

1 joint publications

Tom Curran

1 joint publications

Tsukasa Nabekura

1 joint publications

Eric Vivier